MSB 4.89% $1.07 mesoblast limited

Cell Therapy News/Articles, page-82

  1. 6,121 Posts.
    lightbulb Created with Sketch. 1055
    The drug companies, especially in the US can see other countries moving into the cell therapy and are pushing for regulatory reform to stimulate innovation.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.